Taysha Gene Therapies, Inc. (TSHA) has 31 open-market insider trades by 8 insiders since 2021. The most active filer is Paul B. Manning, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Paul B. Manning | 10% Owner | — | 9 | $43.4M | 2025-05-30 |
| Sukumar Nagendran | Pres | — | 6 | $5.3M | 2026-07-10 |
| Suyash Prasad | CMO | — | 2 | $1.9M | 2022-07-06 |
| R.a. Session II | 10% Owner | — | 4 | $1.8M | 2023-07-13 |
| Sean P. Nolan | CEO | — | 3 | $1.7M | 2026-01-26 |
| Kamran Alam | CFO | — | 4 | $1.3M | 2026-02-04 |
| John A. Stalfort III | Dir | — | 1 | $700K | 2026-06-01 |
| Phillip B. Donenberg | Dir | — | 2 | $223K | 2026-06-01 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Sukumar Nagendran | President | Sell | $1.2M | 2026-07-10 |
| Sukumar Nagendran | President | Sell | $892K | 2026-04-10 |
| Kamran Alam | CFO | Sell | $7K | 2026-02-04 |
| Sukumar Nagendran | President | Sell | $547K | 2026-01-23 |
| Kamran Alam | CFO | Sell | $485K | 2026-01-23 |
| Sean P. Nolan | CEO | Sell | $840K | 2026-01-23 |
Companies that share insiders with TSHA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Sukumar Nagendran | President | Sell | $942K | 2026-01-12 |
| Sukumar Nagendran | President | Sell | $3.4M | 2025-11-28 |
| Sukumar Nagendran | President | Sell | $646K | 2025-09-10 |
| Sukumar Nagendran | President | Sell | $325K | 2025-08-21 |
| Kamran Alam | CFO | Sell | $311K | 2025-08-21 |
| Paul B. Manning | 10% Owner | Buy | $2.1M | 2025-05-30 |
| Paul B. Manning | 10% Owner | Buy | $6.0M | 2024-06-27 |
| Paul B. Manning | 10% Owner | Buy | $163K | 2023-11-17 |
| Kamran Alam | CFO | Sell | $77K | 2023-08-24 |